encyclopedia jump navigation jump search parkinson's_disease 
journal disease journal 
use disambiguation 
parkinson's_disease name parkinson's_disease parkinson's_disease parkinson's_disease parkinson's_disease parkinson's_disease sketche front side man face 
illustration parkinson's_disease william richard gowers manual disease system symptom rigidity slowness movement difficulty walk complication dementia depression anxiety onset age cause risk factor pesticide exposure head injury method symptom diagnosis dementia body palsy tremor use treatment surgery dopamine agonist life expectancy year frequency death 
parkinson's_disease parkinson's_disease disorder system motor system disease symptom symptom disease symptom rigidity slowness movement difficulty walk think behavioral problem dementia stage disease depression anxiety people parkinson's_disease symptom sleep problem motor symptom syndrome 
cause parkinson's_disease factor family member disease risk people pesticide head injury risk tobacco smoker coffee tea motor symptom disease result death cell nigra region midbrain result dopamine region brain cause cell death build-up protein body neuron diagnosis case symptom test rule disease 
cure parkinson's_disease treatment symptom treatment medication l-dopa dopamine agonist disease neuron medication time complication movement diet form rehabilitation effectiveness symptom surgery place brain stimulation motor symptom case drug evidence treatment symptom parkinson's_disease sleep disturbance problem 
parkinson's_disease people death parkinson's_disease people age percent male female ratio people age parkinson's_disease life expectancy diagnosis year disease doctor james parkinson description essay parkinson's_disease awareness campaign world day birthday james parkinson april use tulip symbol disease people parkinson publics awareness condition actor michael  
fox cyclist davis boxer muhammad ali actor alan alda content 
classification sign symptom motor cause factor genetics brain cell death diagnosis image diagnosis prevention management surgery rehabilitation care epidemiology history society culture cost advocacy case research animal model gene therapy neuroprotective treatment therapy reference link 
movement difficulty parkinson's_disease slowness movement reduction speed range action finger-tap combination sign rigidity tremor rest instability 
number disorder type movement issue 
parkinson's_disease form parkinsonism parkinson's_disease mean cause cause parkinsonism toxin infection side effect drug derangement brain lesion stroke 
disorder parkinsonism parkinson syndrome illness parkinsonism feature parkinson's_disease 
system atrophy supranuclear palsy degeneration dementia body 
scientist disease due accumulation protein brain disease alzheimers disease brain tau protein overlap tauopathy synucleinopathy 
contrast parkinson's_disease alzheimers disease memory loss sign parkinson's_disease slowness tremor stiffness instability feature alzheimers 
dementia body similarity parkinson's_disease subset parkinson's_disease case dementia parkinson's_disease dementia 
relationship parkinson's_disease part continuum feature disease sign symptom picture male parkinson's_disease stoop 
side chair 
man parkinson's_disease display walk posture signature catherine handwrit person parkinson's_disease article sign symptom parkinson's_disease 
symptom parkinson's_disease movement motor symptom dysfunction problem mood cognition behavior thought alteration sense smell sleep difficulty 
symptom time diagnosis motor information gait 
motor symptom parkinson's_disease tremor slowness movement rigidity instability 
sign tremor hand rest movement arm stage sleep hand hand disease frequency parkinson's_disease tremor hertz cycle second 
feature tremor tendency index finger thumb touch movement term similarity movement people parkinson's_disease technique pill 
slowness movement case parkinson's_disease disturbance motor plan movement initiation difficulty course movement process plan initiation execution movement 
performance movement 
symptom disease difficulty task dress feed bath 
difficulty motor activity time stress illness 
patient parkinson's_disease bicycle climb stair walk level 
physician assessment patient movement finger feet 
stiffness resistance limb movement muscle tone contraction muscle parkinsonism rigidity rigidity rigidity combination tremor tone origin rigidity rigidity pain pain manifestation disease stage parkinson's_disease rigidity neck shoulder muscle muscle face extremity progression disease rigidity body ability 
instability stage disease balance fall bone fracture loss confidence mobility instability stage people development symptom people parkinson's_disease fall fall number fall severity parkinson's_disease 
motor sign symptom gait posture disturbance shuffle step posture arm swing 
gait arrest feet floor turn direction voice expression handwrit sign 
parkinson's_disease disturbance 
disorder cognition mood behavior thought 
disturbance stage disease diagnosis increase prevalence duration disease deficit parkinson's_disease executive dysfunction problem flexibility think rule acquisition action action memory control attention difficulty process speed recal perception estimation time improvement recal cue difficulty part disease example individual test recognition perception orientation line 
person parkinson's_disease time risk dementia population people parkinson's_disease parkinson's_disease dementia prevalence dementia increase age degree duration disease dementia quality life people parkinson's_disease mortality probability nurse home care 
control disorder gamble behavior binge shop generosity medication dopamine agonist 
dopamine syndrome medication overusage complication use 
mood alteration parkinson's_disease impairment population parkinson's_disease dementia 
mood difficulty depression apathy anxiety diagnosis depression fact body language depression parkinson's_disease face hang dog appearance movement speech 
people parkinson's_disease symptom anxiety anxiety_disorder phobia panic disorder disorder 
quality life severity motor symptom fluctuation episode 
behavior hour disturbance medication 
delusion people parkinson's_disease course illness emergence dementia 
range hallucination sense passage person sense presence perception stand side person hallucination ideation 
hallucination parkinson's_disease voice 
psychosis part disease 
psychosis delusion delirium complication drug treatment tract infection drug infection factor brain pathology change neurotransmitter receptor acetylcholine serotonin role psychosis parkinson's_disease 
addition neuropsychiatric motor symptom parkinson's_disease function 
sleep_disorder feature disease medication symptom daytime drowsiness sleep attack disturbance rem sleep insomnia rem behavior disorder patient dream bed partner year development motor feature parkinson's_disease dlb 
alteration system hypotension blood pressure skin sweate incontinence function constipation stomach dysmotility discomfort health change perception sense smell vision pain tingle numbness symptom year diagnosis disease cause article cause parkinson's_disease 
risk factor relation theory mechanism disease relationship risk pesticide risk smoker link parkinson's_disease  pylory infection absorption drug factor 
exposure pesticide history head injury parkinson's_disease parkinson's_disease risk 
cigarette beverage increase risk parkinson's_disease 
concentration urate blood serum risk parkinson's_disease genetics parkin crystal structure 
research parkinson's_disease product interaction factor individual parkinson's_disease relative disease people parkinson's_disease form disease mutation gene gene mutation disease susceptibility factor individual risk combination risk factor age onset severity progression autosomal gene mutation development parkinson's_disease lrrk2park8 pink1 dnajc13 
people parkinson's_disease mutation gene mutation population 
risk parkinson's_disease fold mutation 
parkinson's_disease mutation feature age onset decline 
gene mutation parkinson's_disease protein gene component body brain people parkinson's_disease mutation gene lrrk2 risk factor non-familial parkinson's_disease mutation gene cause parkinson's_disease account individual family history disease case mutation gba risk disease 
gene function lysosome organelle waste product 
case parkinson's_disease disorder ability cell 
form mutation gene brain cell 
neurone form body 
body diameter cell 
body brain cell nigra parkinson's_disease 
colour immunohistochemistry stain 
article pathophysiology parkinson's_disease 
characteristics parkinson's_disease cell death brain ganglia dopamine neuron nigra par end life presence body accumulation protein neuron 
loss neuron death cell increase number type cell nigra image row caption row  
top mid-line plane brainstem cerebellum 
circle brainstem arrow bottom top lobe brain 
line text circle 
motor middle 
gain set 
line text 
image bottom resonance image mry sagittal transverse brain coordinate z-49 
blob mark volume reduction brainstem 
progression body deposit stage parkinson's_disease braak colleague area brain volume reduction parkinson's_disease group participant disease study brainstem damage stage parkinson's_disease neuropathology 
pathway brain brain area ganglia 
motor circuit name projection area circuit parkinson's_disease disruption symptom disease circuit variety function movement attention learn motor circuit 
model motor circuit alteration parkinson's_disease influence limitation modification model ganglia influence range motor system time 
decision action inhibition motor system activation 
release inhibition level dopamine function motor activity level dopamine function parkinson's_disease demand exertion effort movement 
effect dopamine depletion reduction motor output drug parkinson's_disease dopamine activity motor system time brain cell death 
speculation mechanism brain cell mechanism accumulation protein ubiquitin cell 
protein neurone inclusion body braak classification disease find braak body bulb medulla individual stage symptom loss sense smell sleep dysfunction 
disease body nigra area midbrain forebrain neocortex brain site place degeneration parkinson's_disease body cell death protein 
form oligomer body neurite form protein people dementia presence body area 
tangle plaque characteristic alzheimers disease person 
cell-death mechanism system dysfunction activity iron accumulation nigra conjunction protein inclusion 
stress protein aggregation death mechanism diagnosis 
physician parkinson's_disease history examination people improvement motor impairment parkinson's_disease diagnosis 
find body midbrain autopsy proof person parkinson's_disease 
course illness time parkinson's_disease presentation accuracy diagnosis 
cause stroke drug parkinson syndrome supranuclear palsy system atrophy medication symptom parkinson syndrome progression rate dysfunction instability tremor symmetry onset parkinson plus disease parkinson's_disease form pattern inheritance parkinson's_disease parkinsonism 
organization criteria ease process stage disease 
criteria uk queen square brain bank disorder 
institute disorder stroke 
queen square brain bank criteria slowness movement rigidity rest tremor instability 
cause symptom 
feature onset evolution onset tremor rest progression time asymmetry motor symptom response year course year appearance dyskinesia intake levodopa 
parkinson's_disease diagnose autopsy movement disorder expert average assessment diagnosis examination 
diagnose nonexpert autopsy average accuracy 
parkinson's_disease diagnose diagnose brain bank criteria 
task force parkinson movement disorder society criteria disease research criteria diagnosis disease validation criteria image 
tomography ct scan people parkinson's_disease mry diagnosis disease time sequence field strength absence swallow tail image pattern dorsolateral nigra meta-analysis absence pattern disease diffusion mry potential parkinson's_disease parkinson syndrome value investigation ct mry rule disease cause encephalitis ischemic insult entity ganglia 
activity dopamine transporter ganglia pet spect scan datscan version study 
agreement diagnose dopamine-relate activity ganglia parkinsonism 
find parkinson's_disease parkinson-plus disorder united states fda disease parkinsonian syndrome tremor diagnosis 
condition presentation parkinson's_disease 
arthritis syndrome dementia body depression drug x-associate syndrome dementia parkinsonism chromosome disease ganglia system atrophy brain iron accumulation slowness supranuclear palsy wilsons disease vascular 
age risk parkinson's_disease life caffeine decrease risk intake beverage coffee people cigarette use tobacco non-smoker parkinson's_disease tobacco parkinson's_disease 
tobacco use parkinson's_disease factor risk parkinson's_disease aversion tobacco tobacco 
vitamin disease result study effect result fat acid study effect effect effect indication use drug calcium channel blocker meta-analysis drug aspirin percent user reduction incidence development parkinson's_disease management article management parkinson's_disease treatment parkinson's_disease 
cure parkinson's_disease medication surgery treatment relief treatment disorder alzheimers disease motor neuron disease parkinson syndrome 
family drug motor symptom dopa inhibitor inhibitor dopamine agonist inhibitor 
stage disease age disease onset group 
stage parkinson's_disease stage stage stage stage 
stage disability treatment stage development complication usage stage symptom dopamine deficiency treatment 
treatment stage aim trade-off symptom control treatment side-effect 
start treatment medication inhibitor dopamine agonist hope onset complication use treatment motor symptom parkinson's_disease patient quality life 
duration severity disease duration treatment therapy time use 
stage aim parkinson's_disease symptom fluctuation effect medication 
withdrawal medication overuse medication control symptom surgery brain stimulation wake day infusion dopa pump stage parkinson's_disease challenge variety treatment symptom depression hypotension bladder dysfunction dysfunction stage disease care quality life 
motor symptom parkinson's_disease result dopamine production brain ganglia 
barrier medicine brain level dopamine 
precursor dopamine brain dopamine administration motor symptom parkinson's_disease 
parkinson's_disease treatment year 
cross barrier 
remainder dopamine body variety side effect nausea vomit hypotension inhibitor barrier conversion levodopa dopamine brain side effect availability levodopa passage brain 
drug levodopa pill 
term development complication movement fluctuation effectiveness medication fluctuation person phase response medication parkinson's_disease symptom state phase response medication parkinson's_disease symptom state dose levodopa risk severity complication strategy dyskinesia fluctuation medication time 
side effect syndrome people parkinson's_disease fluctuation dyskinesia 
controlled-release preparation absorption bioavailability control parkinson's_disease motor symptom reduction complication release preparation 
extended-release preparation fluctuation patient problem 
infusion duodopa improvement fluctuation levodopa fluctuation uptake 
oral formulation study mode delivery inhibitor 
activity enzyme dopamine complement usefulness complication liver damage drug entacapone alteration liver function preparation entacapone combination carbidopa levodopa agonist 
dopamine agonist dopamine receptor brain effect therapy individual complication fluctuation therapy motor symptom parkinson's_disease aim initiation therapy onset complication agonist pergolide cabergoline 
dopamine agonist parkinson's_disease motor symptom symptom year treatment dopamine agonist people parkinson's_disease complication age onset dopamine agonist treatment onset parkinson's_disease onset parkinson's_disease 
agonist side effect drowsiness hallucination insomnia nausea constipation side effect dose physician search drug impulse control disorder activity eate gamble shop 
dopamine agonist period dyskinesia parkinson's_disease injection infusion effect confusion hallucination individual treatment dopamine agonist skin patche people stage control state state inhibitor 
inhibitor selegiline increase amount dopamine ganglia activity oxidase enzyme dopamine dopamine agonist use commencement therapy disease mao-b inhibitor effect parkinson's_disease motor symptom 
study effectiveness stage result fluctuation period study selegiline combination levodopa risk death drug article medication 
drug treatment motor symptom 
evidence quality choice treatment addition motor symptom parkinson's_disease range symptom 
number drug problem example use quetiapine psychosis inhibitor dementia modafinil daytime sleepiness pimavanserin management parkinson's_disease psychosis 
fatigue parkinson's_disease surgery placement electrode brain 
head frame surgery 
motor symptom surgery practice discovery levodopa number operation study past decade improvement technique surgery people parkinson's_disease drug therapy surgery parkinson's_disease group brain stimulation dbs 
target area dbs lesion thalamus globus nucleus brain stimulation treatment alim louis 
implantation device neurostimulator impulse part brain 
dbs people parkinson's_disease motor fluctuation tremor medication medication problem therapy formation lesion area 
example destruction pallidus control 
area brain stimulator parkinson's_disease globus thalamus nucleus nucleus 
dbs pallidus motor function dbs thalamic dbs tremor effect bradykinesia rigidity 
dbs nucleus history depression impairment 
dbs nucleus reduction medication 
nucleus dbs 
dbs improvement motor score evaluation 
rehabilitation information rehabilitation parkinson's_disease 
exercise program people parkinson's_disease evidence speech mobility problem rehabilitation study quality exercise therapy mobility flexibility strength gait speed quality life exercise program supervision physiotherapist improvement motor symptom function live activity quality life exercise program home term flexibility range motion people rigidity relaxation technique rock muscle tension 
technique relaxation movement extremity trunk initiation breath meditation technique gait challenge disease slowness movement shuffle arm swing physiotherapist variety strategy mobility safety 
area interest respect gait rehabilitation program focus gait speed base support stride length trunk arm swing movement 
strategy equipment pole walk treadmil cue manual exercise pattern environment surface input strengthen exercise improvement strength motor function people weakness weakness inactivity parkinson's_disease 
report interaction strength time medication 
people parkinson's_disease exercise minute hour medication posture dysfunction parkinson's_disease breath exercise chest wall mobility capacity exercise constipation exercise fatigue parkinson's_disease 
treatment speech_disorder parkinson's_disease lee silverman voice treatment speech therapy speech therapy ot health quality life people disease live activity study effectiveness ot quality indication motor skill quality life duration therapy care 
care care people illness 
goal speciality quality life person parkinson family relief symptom pain stress illness disease treatment decline quality life nature 
care disease course care specialist symptom factor loss function job depression fear concern 
support patient family palliative care role goal care 
people parkinson decision disease wishe tube ventilator tracheostomy wishe resuscitation hospice care care team member answer question guide people parkinson complex topics decision value 
muscle nerve process parkinson's_disease constipation food stomach period diet periodical assessment weight loss gain consequence dysfunction disease advance difficulty dysphagia 
case thicken agent intake posture measure risk 
food stomach case 
protein transportation system intestine barrier access result effectiveness drug protein consumption diet 
stage intake product bread pasta reason interaction protein minute meal time regimen parkinson's_disease protein breakfast lunch protein intake even parkinson's_disease rate scale burden parkinson's_disease life year inhabitant data  
parkinson's_disease time 
severity rate method parkinson's_disease rate scale  parkinson's_disease rs study 
version mds-u parkinson's_disease rs 
scale method hoehn scale scale hoehn scale 
hoehn scale stage progression 
motor symptom advance stage disease 
individual ambulation average year year people 
prognosis motor symptom time source disability effect levodopa year use people progression time symptom stage dependency caregiver year course disease age predictor disease progression rate motor decline impairment time diagnosis impairment year age symptom onset 
therapy symptom disability present feature disease relationship disease progression disability 
disability motor symptom disease advance disability motor symptom medication difficulty problem complication individual year usage year people disease disturbance sleep problem mood alteration decline symptom decline increase disability 
life expectancy people parkinson's_disease mortality ratio people decline dementia age onset disease state presence problem mortality risk factor 
hand disease pattern tremor rigidity survival death aspiration pneumonia individual parkinson's_disease population 
parkinson's_disease death death death rate average time epidemiology death parkinson's_disease person   
parkinson's_disease second neurodegenerative disorder alzheimers disease people people united states proportion population time country 
parkinson's_disease rate rise year age population age onset year case onset parkinson's_disease age male female ratio parkinson's_disease ancestry find study men women difference sexe number case year parkinson's_disease age rate parkinson's_disease estonia person year rate history article history parkinson's_disease jean-martin contribution understand disease name james parkinson 
source papyrus treatise bible galen write symptom parkinson's_disease galen reference parkinson's_disease century century author element disease sylvius gaubius hunter chomel 
doctor james parkinson essay report case parkinson's_disease essay parkinson's_disease rest tremor posture gait paralysis muscle strength way disease time addition knowledge disease gowers wilson erb study landmark understand disease advance distinction rigidity weakness renam disease honor james parkinson 
frederic lewy particle brain body konstantin tretiakoff nigra structure find study rolf change brain work arvid carlsson neurotransmitter dopamine hornykiewicz role parkinson's_disease alpha-synuclein component body trojanowsky 
surgery lesion pathway ganglia structure treatment arrival levodopa use casimir funk attention century practice revolution management parkinson's_disease brain stimulation alim louis colleague grenoble france treatment society culture cost awareness logo tulip symbol 
cost parkinson's_disease society calculation issue research difference country cost uk cost patient year burden share cost inpatient care nurse home share medication cost productivity burden caregiver addition cost parkinson's_disease quality life disease advocacy 
april birthday james parkinson world day tulip organization symbol disease james parkinson tulip horticulturalist advocacy organization parkinson foundation care research support service parkinson's_disease foundation research education advocacy program found william black parkinson's_disease association parkinson's_disease association case article list people parkinson's_disease muhammad ali world forum davos age 
sign parkinsonism age death 
actor michael  
fox parkinson's_disease awareness disease diagnosis fox parkinson television role medication order effect condition 
autobiography fight disease role united states congress medication effect disease michael  
fox foundation cure parkinson's_disease fox doctorate medicine institutet contribution research parkinson's_disease 
cyclist davis onset age davis phinney foundation research quality life people disease 
boxer muhammad ali sign parkinson world parkinson patient parkinson's_disease box research parkinson's_disease research 
prospect parkinson's_disease treatment future research direction search animal model disease study usefulness gene therapy stem cell transplant agent animal model 
parkinson's_disease specy human animal model feature disease research 
appearance parkinsonism group drug addict batch opiate discovery mptp agent primate human model insecticide herbicide fungicide model toxin primate 
rodent model aspect parkinson's_disease use 6-hydroxydopamine model parkinson's_disease rat target neuron pathway nigra gene therapy 
gene therapy use virus vector virus shuttle material part brain 
gene production enzyme parkinson's_disease symptom brain damage trial gene therapy parkinson's_disease effect trial usefulness gene therapy result company bankruptcy march treatment compound structure neuroprotector parkinson's_disease effectiveness 
investigation neuroprotection forefront parkinson's_disease research 
molecule treatment degeneration agent investigation oxidase inhibitor promitochondrial calcium channel blocker growth factor research target vaccine system parkinson's_disease 01a company affiris trial human vaccine stage trial stage trial therapy article therapy parkinson's_disease 
tissue cell transplant cell nigra hope brain way cell evidence cell transplant trial date cell transplant benefit problem release dopamine tissue stem cell transplant research target stem cell cell brain rodent monkey abnormality use stem cell treatment way use pluripotent stem cell adult 
stimulation usefulness parkinson's_disease research topic nutrient treatment evidence vitamin food additive symptom evidence acupuncture practice qigong tay chy effect course disease symptom bean velvet bean source levodopa people parkinson's_disease intake risk reaction syndrome 
role axis gut flora parkinsons topic study start work mice transplant people parkinson's_disease outcome 
study human correlation pattern dysbiosis gut flora people parkinson's_disease pattern measure severity constipation parkinson's_disease specificity sensitivity 
scientist change gut flora site parkinson's_disease pathology part pathology 
